TGF-β is an important immunosuppressive factor in tumors, which contributes to the formation of promotion of tumor inflammatory microenvironment, and diminishes the efficacy of checkpoint inhibition immunotherapy (Mariathasan et al., 2018; Tauriello et al., 2018). Here, TGFB1 is linked to neoplasm.